Citral Protects Human Endothelial Cells Against Hydrogen Peroxide-induced Oxidative Stress

Abstract

Objectives:

Oxidative stress plays a major role in endothelial dysfunction. Citral is a monoterpene aldehyde with antioxidant properties. This study aimed to investigate the effect of citral on human umbilical vein endothelial cells (HUVECs) under hydrogen peroxide (H₂O₂)-induced oxidative stress.

Materials and Methods:

The cells were treated with citral (0.625-10 μg/mL) for 24 h before exposure to H₂O₂ (0.5 mM, 2 h). Cell viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. The hydroperoxide concentrations and ferric reducing ability of plasma (FRAP) were measured in intra- and extracellular fluids.

Results:

Pretreatment of HUVECs with citral at concentrations of 5 and 10 μg/mL significantly enhanced the cell viability in H₂O₂-induced cytotoxicity. It reduced intracellular hydroperoxide levels at the concentrations of 5 and 10 μg/mL and extracellular hydroperoxide levels at the concentrations of 2.5-10 μg/mL. Pretreatment with citral significantly increased the FRAP value in intra- and extracellular fluids at the concentration range of 1.25-10 μg/mL.

Conclusion:

Antioxidant and cytoprotective effects were found for citral against oxidative damage induced by H₂O₂ in human endothelial cells. However, more studies in this area are needed to assess its clinical value for prevention and treatment of cardiovascular diseases.

INTRODUCTION

Cardiovascular diseases (CVDs) are the most prominent causes of death worldwide.¹ Many studies have confirmed the pivotal role of oxidative stress in the pathogenesis and progression of CVDs. Oxidative stress is a state of overproduction of free radicals and an imbalance between oxidants and antioxidants. Cellular damage and endothelial dysfunction resulting from excessive generation of reactive oxygen species (ROS) have been reported to be involved in various CVDs.² Superoxide anion, hydroxyl radicals, lipid radicals, and hydrogen peroxide (H₂O₂) are examples of ROS in the vascular system. ROS have a physiological role in controlling cardiovascular homeostasis by mediating diverse biological responses such as induction of host defense genes, activation of transcription factors, phosphorylation of kinases, and mobilization of ion transport systems.^3,4 Besides their physiological role, ROS also play an important pathophysiological role in inflammation, hypertrophy, proliferation, apoptosis, migration, fibrosis, angiogenesis, vascular remodeling, and endothelial dysfunction.^5,6

Natural antioxidants are widely distributed in fruits, vegetables, and medicinal plants, produced via the secondary metabolisms and possessing various biological activities.^7,8 In many investigations, herbal antioxidants and bioactive plant constituents have been associated with beneficial therapeutic effects and a reduction in the risk of CVDs.⁹

Citral (3,7-dimethyl-2,6-octadienal) is one of the most important natural flavoring compounds, widely used in the food, pharmaceutical, and cosmetic industries.¹⁰ This monoterpene aldehyde also called lemonal and is a mixture of geranial (trans-citral or citral A) and neral (cis-citral or citral B).¹¹ Citral is present in several plants with lemon aroma such as lemongrass (Cymbopogon citratus) and lemon balm (Melissa officinalis).^12,13 This essential oil has exhibited antifungal, bactericidal, insecticidal, anticancer, analgesic, anti-inflammatory, anticonvulsant, and spasmolytic activities in pharmacological studies.^10,14 Moreover, some beneficial cardiovascular effects have been reported for citral due to its antioxidant, radical scavenging, anti-inflammatory, and vasodilatory properties.^15,16 The present study aimed to investigate the possible protective effects of citral against oxidative damage induced by H₂O₂ in human umbilical vein endothelial cells (HUVECs).

MATERIALS AND METHODS

Cell culture

HUVECs were maintained in Dulbecco’s Modified Eagle’s Medium in a humidified atmosphere of 5% CO₂ at 37 °C. The medium was supplemented with 10% fetal bovine serum, 100 µ/mL penicillin, and 100 µg/mL streptomycin. Citral (Sigma, Germany) was dissolved in dimethyl sulfoxide 0.8% and diluted with cell culture medium to get different concentrations as required.

Cell viability assay

The viability of HUVECs was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- tetrazolium bromide (MTT) assay (Bioidea Co., Tehran, Iran) for evaluation of the potential cytotoxicity of citral under normal conditions and its possible cytoprotective effect against oxidative stress.¹⁷ In brief, the cell monolayer in exponential growth was harvested and 1.5x10⁵ cells/mL were seeded in each well of the 96-well plates. Twenty-four hours after plating, the HUVECs were treated with 0.625 to 100 µg/mL citral and incubated for an additional 24 h for assessment of the effect of citral on HUVEC proliferation under normal conditions. After washing out with butylene succinate (PBS), MTT reagent was added to each well, followed by further incubation for 3 h. Then dimethyl sulfoxide was used and the absorbance was measured at 570 nm by a microplate reader.

For evaluation of the cytoprotective effect of citral on HUVECs against H₂O₂-induced oxidative stress, the cells were pre-incubated with 0.625 to 10 µg/mL citral for 24 h and then the citral was removed from the media and the wells were washed out with PBS. After that the cells were exposed to 0.5 mM H₂O₂ for 2 h. The rest of the experiment was performed as above. The cells without any exposure to the extract or H₂O₂ were considered the negative control. The viability of treated samples was measured according to the following formula and each experiment was tested in triplicate:

Cell viability (%) = (OD test - OD blank/OD negative control - OD blank) × 100

Hydroperoxide assay

A ferrous ion oxidation by xylenol orange (FOX-1) kit (Hakiman Shargh Research Co., Isfahan, Iran) was used for evaluation of the effects of pretreatment with citral on intra- and extracellular hydroperoxide levels. In this method, hydroperoxides are detected based upon oxidation of reagent Fe⁺² to Fe⁺³ by oxidizing agents and formation of a color complex through its binding to xylenol orange in an aqueous medium containing sorbitol.¹⁸ Ten milliliters of supernatant of the cells or the cell lysates after being pretreated with different concentrations of citral and then exposed to H₂O₂ was mixed with 190 µL of FOX-1 reagent. After incubation for 30 min at 40 °C, the absorbance was measured at 540 nm using a microplate reader/spectrophotometer. The hydroperoxide content of the samples was estimated as H₂O₂ equivalents using a H₂O₂ standard curve.

Ferric reducing ability of plasma assay (FRAP)

The effects of citral on the intra- and extracellular FRAP was determined by a commercial kit (Hakiman Shargh Research Co., Isfahan, Iran).¹⁹ In this assay, the total antioxidant capacity is estimated based on the reduction of ferric-tripyridyltriazine complex to ferrous form. Briefly, after pretreatment of HUVECs with different concentrations of citral and then exposure to H₂O₂, 10 µL of the supernatant of the cells or the cell lysates was added to 200 µL of FRAP reagent containing tripyridyltriazine/ferric chloride/acetate buffer. The reaction mixture was incubated for 40 min at 40 °C and absorbance was read at 570 nm using a microplate reader/spectrophotometer. The FRAP values of the samples were calculated using a standard curve of FeSO₄x7H₂O concentrations and were expressed as FeII equivalents.

Statistical analysis

The data were presented as mean ± standard error of the mean. For statistical analysis, One-Way ANOVA followed by Tukey’s post-hoc test was performed using SPSS version 18.0. A p value <0.05 was considered significant.

RESULTS

Effect of citral on HUVEC viability

The potential cytotoxicity of citral on HUVECs was evaluated by MTT assay. There was an inhibitory effect on HUVEC proliferation after 24 h exposure to the concentrations of 20-100 µg/mL of citral (p<0.001 compared with control cells) (Figure 1). Therefore, citral was used at the concentration range of 0.625-10 µg/mL for further studies.

Figure 1.

Effect of citral on HUVEC viability determined by MTT assay. Cells were incubated with different concentrations of citral (0.625-100 μg/mL) for 24 h. Values are means ± SEM from three independent experiments in triplicate. ***p<0.001 versus control (untreated cells)

HUVEC: Human umbilical vein endothelial cell, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, SEM: Standard error of the mean

Effect of citral on H₂O₂-induced oxidative stress

Figure 2 shows the cytoprotective effect of citral against oxidative cell death induced by H₂O₂ using an MTT assay. H₂O₂ (0.5 mM) produced a significant reduction in HUVEC viability compared with the control cells (p<0.001). Pretreatment with citral at the concentrations of 5 and 10 µg/mL significantly enhanced cell viability in H₂O₂-induced cytotoxicity (p=0.005 and p<0.001, respectively).

Figure 2.

Effect of citral on HUVEC viability in H₂O₂-induced oxidative stress determined by MTT assay. Cells were incubated with H₂O₂ (0.5 mM, 2 h) after pretreatment with different concentrations of citral (0.625-10 μg/mL). Values are means ± SEM from three independent experiments in triplicate. ###p<0.001 versus control (untreated cells), **p<0.01 and ***p<0.001 versus H₂O₂ stimulated cells

HUVEC: Human umbilical vein endothelial cell, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, SEM: Standard error of the mean

Effects of citral on hydroperoxide levels

The FOX-1 assay was performed to detect the effects of citral on intra- and extracellular hydroperoxide concentrations in HUVECs after exposure to the oxidative stress induced by H₂O₂. A significant increase in hydroperoxide production was observed in the presence of 0.5 mM H₂O₂ as compared to the untreated normal control (p<0.001). Incubation of HUVECs with citral significantly decreased the intracellular hydroperoxide levels at the concentrations of 5 µg/mL (p=0.35) and 10 µg/mL (p=0.001) compared to the cells treated with H₂O₂ alone (Figure 3A). Citral also caused a significant reduction in the extracellular hydroperoxide levels at the concentrations of 2.5, 5, and 10 µg/mL (p=0.003, p<0.001, and p<0.001, respectively) (Figure 3B).

Figure 3.

Effect of citral on intra- A) and extracellular B) hydroperoxide concentration in HUVECs as H₂O₂ equivalents determined by FOX-1 method. Cells were incubated with H₂O₂ (0.5 mM, 2 h) after pretreatment with different concentrations of citral (0.625-10 μg/mL). Values are means ± SEM from three independent experiments in triplicate. ###p<0.001 versus control (untreated cells), *p<0.05, **p<0.01, and ***p<0.001 versus H₂O₂ stimulated cells

HUVEC: Human umbilical vein endothelial cell, FOX-1: Ferrous ion oxidation by xylenol orange, SEM: Standard error of the mean

Effects of citral on FRAP value

The effect of citral on total antioxidant capacity was evaluated by FRAP assay. Exposure of HUVECs to H₂O₂ resulted in a significant decrease in the FRAP value (p=0.007). Pretreatment with citral significantly increased the FRAP value in intracellular fluids at the concentrations of 1.25, 2.5, 5, and 10 µg/mL (p=0.025, p=0.004, p=0.002, and p=0.003, respectively) (Figure 4A). It also improved the FRAP value in extracellular fluids at the concentrations of 1.25, 2.5, 5, and 10 µg/mL (p=0.016, p=0.001, p<0.001, and p<0.001, respectively) (Figure 4B).

Figure 4.

Effect of citral on intra- A) and extracellular B) FRAP value in HUVECs determined as ferrous sulfate equivalents. Cells were incubated with H2O2 (0.5 mM, 2 h) after pretreatment with different concentrations of citral (0.625-10 μg/mL). Values are means ± SEM from three independent experiments in triplicate. ##p<0.01 versus control (untreated cells), *p<0.05, **p<0.01, and ***p<0.001 versus H2O2 stimulated cells

FRAP: Ferric reducing ability of plasma, HUVECs: Human umbilical vein endothelial cells

DISCUSSION

The findings of the present study showed cytoprotective and antioxidant effects of citral against oxidative stress induced by H₂O₂ in HUVECs. Citral protected the cells against oxidative cell death at the concentrations of 5 and 10 µg/mL. It reduced hydroperoxide levels and increased the FRAP value in both intra- and extracellular fluid at different concentration ranges.

H₂O₂ is a stable ROS with capability of readily diffusing through the cellular membrane and plays a significant role in vascular cell signaling such as proliferation, apoptosis, and inflammation.²⁰ H₂O₂ as a trigger of oxidative stress in human endothelial cells has been used in many studies to provide insight into the mechanisms of CVD development. In the present study, the exposure of HUVECs to H₂O₂ caused significant reductions in cell viability and the FRAP value and an increase in hydroperoxide levels.

Citral, the major constituent of the essential oil of lemon-scented plants, has been reported to possess several pharmacological activities.¹¹ Studies have shown that citral dose- and time-dependently protects some normal cells against distressing stimuli. At higher concentrations, it may show a cell growth inhibitory effect.²¹ Our results showed the cytoprotective activity of citral at concentrations less than 20 µg/mL. Nordin et al.²² reported similar results for the effect of citral on the proliferation of normal spleen cells.

In the present investigation, citral also exhibited antioxidant effects through reducing hydroperoxides level and elevating the FRAP value in intra- and extracellular fluids. Measurement of ROS provides important data to study the effects of oxidative stress inducers and antioxidant remedies. FOX-1 is a sensitive assay for detection of hydroperoxides in biological samples.¹⁸ This assessment was performed to detect the effects of citral on intra- and extracellular hydroperoxide concentrations in HUVECs after exposure to oxidative stress induced by H₂O₂. The effect of citral on total antioxidant capacity was evaluated by FRAP assay. Antioxidants are enzymes or nonenzymatic compounds involved in the defense mechanisms against oxidative injuries induced by free radicals through preventing ROS creation and scavenging or eliminating ROS.²³ FRAP is a simple and rapid colorimetric measurement widely used for screening of nonenzymatic antioxidants.¹⁹ Several studies have reported the antioxidant properties of the phytochemicals in citrus plants.²⁴ Radical scavenging activity and induction of enzymatic and nonenzymatic cellular antioxidants have been presented for monoterpenes.¹⁴ Cytoprotective and antioxidant effects have been described for Melissa officinalis extract as a plant containing a high level of citral against H₂O₂-induced oxidative stress in endothelial cells.²⁵ Vimal et al.¹⁶ showed the in vitro antioxidant effects of some essential oil compounds including citral through evaluation of free radical scavenging, lipid peroxidation, and antioxidant enzymes activities. Bouzenna et al.²⁶ reported a protective effect of citral against aspirin-induced oxidative stress through attenuation of mitogen-activated protein kinases, reduction of malondialdehyde level, and modulation of superoxide dismutase and glutathione activities. Protection against high glucose-induced oxidative stress has also been found for citral through inhibiting the ROS activated protein kinases signaling pathway in HepG2 cells.²⁷

Besides antioxidant properties, some studies have revealed anti-inflammatory effects of citral by suppression of pro-inflammatory cytokines such as tumor necrosis factor-a and interleukins (IL-6 and IL-8), inhibition of inducible endothelial nitric oxide synthase transcription, reduction of p50 nuclear factor-kB levels, and suppression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and cyclooxygenase-2 expression.^28,29,30,31

Moreover, the helpful vascular effects including vasodilatory effect likely through affecting the intracellular calcium concentration and nitric oxide pathway have been found for citral in isolated aorta.¹⁵ Regarding the beneficial cardiovascular activities such as antioxidant, cytoprotective, anti-inflammatory, and vasorelaxant effects, citral as a natural component could be suggested for prevention of vascular oxidative stress and endothelial dysfunction and consequently prevention of CVDs.

CONCLUSION

Citral was found to protect HUVECs against oxidative damage induced by H₂O₂ by enhancing total antioxidant capacity and reducing hydroperoxide production. However, more studies in this area are required to evaluate its clinical value for prevention and treatment of CVDs.